Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(CSE:MDMA)

0.1000 -0.0050 (-4.76%)
Streaming Delayed Price Updated: 3:30 PM EDT, Jun 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 124,200
Open 0.1050
Bid (Size) 0.0950 (184,000)
Ask (Size) 0.1050 (19,500)
Prev. Close 0.1050
Today's Range 0.1000 - 0.1050
52wk Range 0.0650 - 0.3400
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
PharmAla Completes Shipment of LaNeo™ MDMA to Yale University, Provides Investor Update
From PharmAla Biotech
Via GlobeNewswire
PharmAla Contracts with Partner to Act as US Distributor
From PharmAla Biotech
Via GlobeNewswire

Performance

YTD
-63.0%
-63.0%
1 Month
-28.6%
-28.6%
3 Month
-42.9%
-42.9%
6 Month
-68.3%
-68.3%
1 Year
-16.7%
-16.7%

More News

Read More
PharmAla to supply STRONG STAR at UT Health San Antonio, with novel dosage form of LaNeo™ MDMA
From PharmAla Biotech
Via GlobeNewswire
PharmAla Signs Advisory Agreement with Mr. Matthew Azrieli
From PharmAla Biotech
Via GlobeNewswire
PharmAla To Supply Merhavim Mental Health Centre Clinical Trial in Exchange for Full Data License, in Partnership with MAPS Israel
From PharmAla Biotech
Via GlobeNewswire
PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA
From PharmAla Biotech
Via GlobeNewswire
PharmAla Launches MDMA Clinical Trial Tool for Researchers
From PharmAla Biotech
Via GlobeNewswire
PharmAla Comments on USFDA Decision regarding MDMA-Assisted Therapy and Announces Patent Granting for ALA-002
From PharmAla Biotech
Via GlobeNewswire
Canadian Biotech Duo Hits Psilocybin Extraction Milestone For API Development At Scale
Via Benzinga
Cortexa Commences Manufacturing GMP LaNeo™ MDMA in Australia
From PharmAla Biotech
Via GlobeNewswire
Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office
From PharmAla Biotech
Via GlobeNewswire
Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office
From PharmAla Biotech
Via GlobeNewswire
Cortexa Leads the World in First Supply of Psilocybin Under the TGA’s Authorized Prescriber Scheme
From PharmAla Biotech
Via GlobeNewswire
PharmAla receives new “MDXXF” ticker from FINRA for OTCQB Listing
From PharmAla Biotech
Via GlobeNewswire
PharmAla-1 Molecule Receives US Patent Prosecution Highway Acceptance
From PharmAla Biotech
Via GlobeNewswire
PharmAla Begins Trading on OTCQB
From PharmAla Biotech
Via GlobeNewswire
PharmAla Files Patent for Novel MDXX Molecule PharmAla-1
From PharmAla Biotech
Via GlobeNewswire
Life Science Investor Forum: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
Life Science Investor Forum Agenda Announced for June 22nd
From Virtual Investor Conferences
Via GlobeNewswire
USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States
From PharmAla Biotech
Via GlobeNewswire
PharmAla Biotech to form Australian Psychedelics Joint Venture with Vitura Health
From PharmAla Biotech
Via GlobeNewswire
Revive Therapeutics Secures MDMA Supply from PharmAla Biotech for MDMA Transdermal Patch Development
From Revive Therapeutics Ltd.
Via GlobeNewswire
Australia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory Change
From PharmAla Biotech
Via GlobeNewswire
The Power Play by The Market Herald Releases New Interviews with Pharmala Biotech Holdings, Nextech AR Solutions and Enertopia Discussing Their Latest News
Via ACCESSWIRE
KCSA Mental Health Virtual Investor Conference: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire

Frequently Asked Questions

Is MDMA publicly traded?
Yes, MDMA is publicly traded.
What exchange does MDMA trade on?
MDMA trades on the Canadian Securities Exchange
What is the ticker symbol for MDMA?
The ticker symbol for MDMA is MDMA on the Canadian Securities Exchange
What is the current price of MDMA?
The current price of MDMA is 0.1000
When was MDMA last traded?
The last trade of MDMA was at 06/06/25 03:30 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.